Use of Florbetapir-PET for Imaging β-Amyloid Pathology (Q22253015)

8 February 2023

Christopher M. Clark

1

Christopher M

Clark

1 reference

8 February 2023

Barry J Bedell

Barry J

Bedell

3

1 reference

8 February 2023

Thomas G Beach

Thomas G

Beach

4

1 reference

8 February 2023

Warren B Bilker

Warren B

Bilker

5

1 reference

8 February 2023

Mark A Mintun

Mark A

Mintun

6

1 reference

8 February 2023

Michael J Pontecorvo

Michael J

Pontecorvo

7

1 reference

8 February 2023

Franz Hefti

Franz

Hefti

8

1 reference

8 February 2023

Alan P Carpenter

Alan P

Carpenter

9

1 reference

8 February 2023

Matthew L Flitter

Matthew L

Flitter

10

1 reference

8 February 2023

Michael J Krautkramer

Michael J

Krautkramer

11

1 reference

8 February 2023

Hank F Kung

Hank F

Kung

12

1 reference

8 February 2023

R Edward Coleman

R Edward

Coleman

13

1 reference

8 February 2023

P Murali Doraiswamy

P Murali

Doraiswamy

14

1 reference

8 February 2023

Adam S Fleisher

Adam S

Fleisher

15

1 reference

8 February 2023

Marwan N Sabbagh

Marwan N

Sabbagh

16

1 reference

8 February 2023

Carl H Sadowsky

Carl H

Sadowsky

17

1 reference

8 February 2023

Eric P Reiman

Eric P

Reiman

18

1 reference

8 February 2023

Simone P Zehntner

Simone P

Zehntner

19

1 reference

8 February 2023

Daniel M Skovronsky

Daniel M

Skovronsky

20

1 reference

The Journal of the American Medical Association

8 February 2023

language of work or name

English

0 references

publication date

19 January 2011

0 references

published in

0 references

volume

305

0 references

issue

3

0 references

page(s)

275

0 references

cites work

Imaging of amyloid beta in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism

1 reference

https://pubmed.ncbi.nlm.nih.gov/21245183

12 December 2020

Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging

1 reference

https://pubmed.ncbi.nlm.nih.gov/21245183

12 December 2020

18F stilbenes and styrylpyridines for PET imaging of A beta plaques in Alzheimer's disease: a miniperspective

1 reference

https://pubmed.ncbi.nlm.nih.gov/21245183

12 December 2020

Neuropathological and neuropsychological changes in "normal" aging: evidence for preclinical Alzheimer disease in cognitively normal individuals.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21245183

12 December 2020

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

1 reference

https://pubmed.ncbi.nlm.nih.gov/21245183

12 December 2020

The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core

1 reference

https://pubmed.ncbi.nlm.nih.gov/21245183

12 December 2020

Diagnosing cognitive impairment and dementia in primary health care - a more active approach is needed

1 reference

https://pubmed.ncbi.nlm.nih.gov/21245183

12 December 2020

The role of biomarkers in clinical trials for Alzheimer disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21245183

12 December 2020

Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21245183

12 December 2020

Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21245183

12 December 2020

Abeta deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21245183

12 December 2020

Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and Apo E4 in medial temporal lobe dementias. Oxford Project to Investig

1 reference

https://pubmed.ncbi.nlm.nih.gov/21245183

12 December 2020

Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain

1 reference

https://pubmed.ncbi.nlm.nih.gov/21245183

12 December 2020

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21245183

12 December 2020

In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18)

1 reference

https://pubmed.ncbi.nlm.nih.gov/21245183

12 December 2020

Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21245183

12 December 2020

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria

1 reference

https://pubmed.ncbi.nlm.nih.gov/21245183

12 December 2020

Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21245183

12 December 2020

Beta-amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia

1 reference

https://pubmed.ncbi.nlm.nih.gov/21245183

12 December 2020

Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21245183

12 December 2020

Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21245183

12 December 2020

Evolution of the neuropathology of Alzheimer's disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21245183

12 December 2020

Whole-body biodistribution and brain PET imaging with [18F]AV-45, a novel amyloid imaging agent--a pilot study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21245183

12 December 2020

The neuropathology of probable Alzheimer disease and mild cognitive impairment

1 reference

https://pubmed.ncbi.nlm.nih.gov/21245183

12 December 2020

PET of brain amyloid and tau in mild cognitive impairment.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21245183

12 December 2020

Whole-body biodistribution and radiation dosimetry of 18F-GE067: a radioligand for in vivo brain amyloid imaging

1 reference

https://pubmed.ncbi.nlm.nih.gov/21245183

12 December 2020

Impact of amyloid imaging on drug development in Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21245183

12 December 2020

Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by [11C]PiB

1 reference

https://pubmed.ncbi.nlm.nih.gov/21245183

12 December 2020

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21245183

12 December 2020

Neuropathology of older persons without cognitive impairment from two community-based studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/21245183

12 December 2020

Cognitive decline and brain volume loss as signatures of cerebral amyloid-beta peptide deposition identified with Pittsburgh compound B: cognitive decline associated with Abeta deposition

1 reference

https://pubmed.ncbi.nlm.nih.gov/21245183

12 December 2020

Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/21245183

12 December 2020

Clinical criteria for the diagnosis of Alzheimer disease: still good after all these years.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21245183

12 December 2020

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

1 reference

https://pubmed.ncbi.nlm.nih.gov/21245183

12 December 2020